Federal Register Notices > Importers Notice of Registration - 2012 > Cerilliant Corporation

Information and Legal Resources Banner

Notice of Registration - 2012


[Federal Register Volume 77, Number 226 (Friday, November 23, 2012)]
[Notices]
[Pages 70186-70187]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-28482]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer Of Controlled Substances; Notice Of Registration; Cerilliant Corporation

By Notice dated August 17, 2012, and published in the Federal Register on August 20, 2012, 77 FR 50162, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application by renewal; to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances:

Drug Schedule
Cathinone (1235) I
Methcathinone (1237) I
4-Methyl-N-methylcathinone (1248) I
N-Ethylamphetamine (1475) I
N,N-Dimethylamphetamine (1480) I
Fenethylline (1503) I
Gamma Hydroxybutyric Acid (2010) I
JWH-018 (7118) I
JWH-073 (7173) I
JWH-200 (7200) I
Alpha-ethyltryptamine (7249) I
Ibogaine (7260) I
CP-47497 (7297) I
CP-47497 C8 Homologue (7298) I
Lysergic acid diethylamide (7315) I
2C-T-7(2,5-Dimethoxy-4-(n)-propylthiophenethylamine) (7348) I
Marihuana (7360) I
Tetrahydrocannabinols (7370) I
Mescaline (7381) I
3,4,5-Trimethoxyamphetamine (7390) I
4-Bromo-2,5-dimethoxyamphetamine (7391) I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxyamphetamine (7396) I
3,4-Methylenedioxyamphetamine (7400) I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
4-Methoxyamphetamine (7411) I
5-Methoxy-N-N-dimethyltryptamine (7431) I
Alpha-methyltryptamine (7432) I
Diethyltryptamine (7434) I
Dimethyltryptamine (7435) I
Psilocybin (7437) I
Psilocyn (7438) I
5-Methoxy-N,N-diisopropyltryptamine (7439) I
N-Benzylpiperazine (7493) I
MDPV 3,4-Methylenedioxypyrovalerone (7535) I
Methylone 3,4-Methylenedioxy-N-methylcathinone (7540) I
Desomorphine (9055) I
Etorphine (except HCl)(9056) I
Heroin (9200) I
Morphine-N-oxide (9307) I
Normorphine (9313) I
Pholcodine (9314) I
Dextromoramide (9613) I
Dipipanone (9622) I
Racemoramide (9645) I
Trimeperidine (9646) I
1-Methyl-4-phenyl-4-propionoxypiperidine (9661) I
Tilidine (9750) I
Amphetamine (1100) II
Methamphetamine (1105) II
Methylphenidate (1724) II
Amobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315) II
Phencyclidine (7471) II
Phenylacetone (8501) II
Cocaine (9041) II
Codeine (9050) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Benzoylecgonine (9180) II
Ethylmorphine (9190) II
Meperidine (9230) II
Methadone (9250) II
Dextropropoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Oripavine (9330) II
Thebaine (9333) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Poppy Straw Concentrate (9670) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

[[Page 70187]]

The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Cerilliant Corporation to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed.

Dated: November 14, 2012.

Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2012-28482 Filed 11-21-12; 8:45 am]

BILLING CODE 4410-09-P

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).

DEA: Drug Enforcement Administration Home